Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer

Loredana Cifaldi; James Di Santo; Daniel Olive

doi:10.3389/fimmu.2020.01132

Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer

Front Immunol. 2020 Jun 16:11:1132. doi: 10.3389/fimmu.2020.01132. eCollection 2020.

Authors

Loredana Cifaldi¹, James Di Santo^{2

3}, Daniel Olive⁴

Affiliations

¹ Academic Department of Pediatrics (DPUO), Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
² Innate Immunity Unit, Institut Pasteur, Paris, France.
³ Institut National de la Santé et de la Recherche Médicale (INSERM) U1223, Paris, France.
⁴ Cancer Research Center of Marseille, INSERM U1068, CNRS U7258, Aix-Marseille University, Institut Paoli-Calmettes, Marseille, France.

No abstract available

Keywords: NK cell-based immunotherapy; NK cells; adoptive transfer of NK and CAR-NK cells; cancer immunotherapy; immune checkpoint inhibitors; ligands for NK cell-activating receptors.

Publication types

Editorial
Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immune Checkpoint Inhibitors / therapeutic use
Immunotherapy / methods*
Immunotherapy, Adoptive / methods
Killer Cells, Natural / immunology*
Neoplasms / immunology*
Neoplasms / therapy*
Tumor Escape / immunology
Tumor Microenvironment / immunology

Substances

Immune Checkpoint Inhibitors